Safety and Efficacy of Ivacaftor in the Treatment of Infants Aged 1 to Less Than 4 Months With Cystic Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis
J Cyst Fibros 2024 May 01;23(3)429-435, P McNally, A Singh, SA McColley, JC Davies, M Higgins, M Liu, J Lu, V Rodriguez-Romero, JL Shih, M RosenfeldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.